Gingival Recession
Conditions
Keywords
connective tissue graft, PRF membrane, gingival recession
Brief summary
This is a split-mouth, randomized, controlled clinical trial that aims to evaluate the clinical efficacy of platelet-rich fibrin (PRF) membranes in conjunction with coronally advanced flap (CAF) in treating maxillary gingival recession defects.
Interventions
PROCEDUREGingival coverage using coronally advanced flap and a connective tissue graft
A coronally advanced flap is applied for recession coverage in the maxilla in a split-mouth randomized trial using a subepithelial connective tissue graft
PROCEDUREGingival coverage using coronally advanced flap and platelet rich fibrin membranes
A coronally advanced flap is applied for recession coverage in the maxilla in a split-mouth randomized trial using platelet rich fibrin membranes
Sponsors
Arab American University (Palestine)
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Greater than 18 years old * Bilateral Miller class I + II recession in the upper jaw
Exclusion criteria
* Smokers * Patients with systemic diseases that could interfere with the healing * Patients undergoing bisphosphonate therap .Patients who previously received radiation therapy of the jaws.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Increase in gingival height (recession coverage) | six weeks | The measurements of the increase in gingival height (recession coverage) using a linear evaluation (corono-apical direction) with a periodontal probe (Merrit-B; Hu-Friedy, Chicago, IL, USA) at the interventions sites to the nearest 0.5 mm. Registration of the recession height was done before treatment and after 6 weeks. |
| Shrinkage in gingival height | six months | To assess the shrinkage of the gingival height, the amount of gingival height vestibular to the treated teeth in a corono-apical direction was measured after the surgery and after six months. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Postoperative pain visual analog scores (VAS) and surgery time | two weeks | This questionnaire used 100 mm visual analog scores VAS to evaluate the amount of pain, ranging from 0 (no pain) to 10 (worst pain imaginable), and the amount of swelling. Patients were asked to fill in the VAS scales at day 7 and day 14 at suture removal. The time of surgery was measured of both treatment options. Timing started at the moment of first incision until the last suture. |
Countries
Palestinian Territories
Outcome results
None listed